Michael Green, PhD

1K posts

Michael Green, PhD banner
Michael Green, PhD

Michael Green, PhD

@GreenLymphoLab

NZ born and raised researcher at @MDAndersonNews focused on the molecular basis for B-cell #lymphoma. Opinions are my own.

Houston, TX Katılım Mart 2015
607 Takip Edilen1.2K Takipçiler
Michael Green, PhD retweetledi
AACR
AACR@AACR·
Register by May 11 to get the lowest rates for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with the ICML and chaired by Michael R. Green. Learn more: brnw.ch/21x1Sht #AACRlymphoma26 @GreenLymphoLab
AACR tweet media
English
0
4
7
1.4K
Michael Green, PhD retweetledi
AACR
AACR@AACR·
Register by May 11 to get the lowest rates for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with the ICML and chaired by Michael R. Green. Learn more: brnw.ch/21x1o6g #AACRlymphoma26
AACR tweet media
English
2
2
1
1.3K
Michael Green, PhD retweetledi
AACR
AACR@AACR·
Deadline Extended:Submit an abstract by April 6 for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with the International Conference on Malignant Lymphoma (ICML). brnw.ch/21x1bbJ #AACRlymphoma26 @GreenLymphoLab
AACR tweet media
English
0
2
3
1.2K
Michael Green, PhD retweetledi
AACR
AACR@AACR·
#AACRlymphoma26 chair Michael R. Green invites you to submit an abstract by March 30 for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with ICML. Learn more: brnw.ch/21x15pZ @GreenLymphoLab
English
0
4
7
1.7K
Michael Green, PhD retweetledi
AACR
AACR@AACR·
Submit an abstract by March 30 for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with the International Conference on Malignant Lymphoma (ICML). Learn more: brnw.ch/21x10Xh #AACRlymphoma26 @GreenLymphoLab
AACR tweet media
English
0
4
1
1.3K
Michael Green, PhD retweetledi
AACR
AACR@AACR·
Submit an abstract by March 30 for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with the International Conference on Malignant Lymphoma (ICML). Learn more: brnw.ch/21x0OLd #AACRlymphoma26 @GreenLymphoLab
AACR tweet media
English
0
5
7
1.2K
Michael Green, PhD
Michael Green, PhD@GreenLymphoLab·
Need PDX models for Lymphoma research? Check out our newest preprint: biorxiv.org/content/10.648… We generated and molecularly characterized 48 new models, including 23 from post-CAR T relapse biopsies. All are available to academic researchers through MTA. #lmsm
English
0
4
15
1.3K
Michael Green, PhD
Michael Green, PhD@GreenLymphoLab·
I would prefer as an author that reviewers have the time they need to review the paper carefully. 4 days does not mean a lot in the life of a study that has taken multiple years.
English
0
0
1
166
Michael Green, PhD
Michael Green, PhD@GreenLymphoLab·
10 day reviews: Is there any data to show that a 10 day reviewer deadline translates to a 4 day quicker turn-around time for authors? When the 4 day reduction in deadline removes a weekend from the review period it makes it much to spend the necessary time on the paper.
English
1
0
4
202
Michael Green, PhD
Michael Green, PhD@GreenLymphoLab·
This provides an initial framework for understanding spatially resolved cellular ecosystems in DLBCL, highlighting how microenvironment architecture can shape disease biology. But we are just scratching the surface.
English
1
0
6
135
Michael Green, PhD
Michael Green, PhD@GreenLymphoLab·
Interestingly, lymphomas of immune privileged sites (CNS & testis) have abundant T cells in close contact with tumor B cells that show evidence of activation and cytotixicity, but also hallmarks of exhaustion.
Michael Green, PhD tweet media
English
1
0
5
195
Michael Green, PhD retweetledi
Pavan Bachireddy
Pavan Bachireddy@pbachi·
Thrilled to share our 1st preprint (!) on @biorxiv “Molecular and cellular dynamics of measurable residual disease (#MRD) progression in myelodysplastic syndromes (MDS).” Led by the indefatigable Yu-Hsiang Chen in the lab (x.com/PhRMAfoundatio…). 👉👉biorxiv.org/content/10.110…
PhRMA Foundation@PhRMAfoundation

#PhF25 awardee Yu-Hsiang Chen, a postdoc @MDAndersonNews, is using single-cell technology to study #cancer cells that remain after stem cell transplant. Understanding these cells could help develop better treatments. @pbachi Watch the full interview: phrmafoundation.org/news-events/bl…

English
2
15
28
8.8K
ESH (Haematology)
ESH (Haematology)@ESHaematology·
Ignition on, this session is all about CAR T. Michael Green (@GreenLymphoLab) dissected mechanisms of CAR T resistance, including factors that impact refractoriness, early & late progression. #ESHCONFERENCES #ESHLYMPHOID2025 Chairs: Veronika Bachanova, Martin Hutchings
ESH (Haematology) tweet mediaESH (Haematology) tweet media
English
1
4
17
1.8K
Michael Green, PhD
Michael Green, PhD@GreenLymphoLab·
@DelgoffeLab Never seen this before, but can't say I'm surprised. Glad you caught it - for now. On the bright side: mimicry is the sincerest form of flattery.
English
1
0
2
743
Delgoffe Lab
Delgoffe Lab@DelgoffeLab·
I want to share a harrowing scientific experience, without exposing too many details, to see if any of my Twitter science friends have seen the same. I was asked to review a ms from a low-mid impact journal. The title caught my eye, so I agreed, but was in for a surprise. 1/
English
6
6
39
5.9K

Keşfet

@UTMDAnderson @AACR @BCD_AACR @NatureGenet @IamLinghua @biorxiv @ESHaematology @DelgoffeLab